Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats.
暂无分享,去创建一个
A. Belló-Klein | R. Teixeira | A. Araujo | A. Zimmer | C. Campos-Carraro | Bruna Gazzi de Lima-Seolin | P. Turck
[1] F. Visioli,et al. The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity. , 2020, European journal of pharmacology.
[2] P. Zhang,et al. Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats , 2019, Front. Pharmacol..
[3] E. Higa,et al. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats. , 2018, Nitric oxide : biology and chemistry.
[4] W. Setzer,et al. Copaifera of the Neotropics: A Review of the Phytochemistry and Pharmacology , 2018, International journal of molecular sciences.
[5] R. Peralta,et al. Copaiba Oil Decreases Oxidative Stress and Inflammation But not Colon Damage in Rats with TNBS-Induced Colitis. , 2018, Endocrine, metabolic & immune disorders drug targets.
[6] K. Yi,et al. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension. , 2016, International immunopharmacology.
[7] B. Popescu,et al. Right ventricular remodeling, its correlates, and its clinical impact in hypertrophic cardiomyopathy. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[8] H. Tsuchiya,et al. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression , 2015, Experimental lung research.
[9] S. Samuel,et al. The endothelium: influencing vascular smooth muscle in many ways. , 2012, Canadian journal of physiology and pharmacology.
[10] L. Rohde,et al. Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction. , 2010, Life sciences.
[11] V. Demarco,et al. Contribution of oxidative stress to pulmonary arterial hypertension. , 2010, World journal of cardiology.
[12] Yves Lecarpentier,et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. , 2004, Chest.
[13] H. Ischiropoulos,et al. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. , 1992, Chemical research in toxicology.
[14] C. Clelland,et al. Impairment of pulmonary endothelium‐dependent relaxation in patients with Eisenmenger's syndrome , 1990, British journal of pharmacology.
[15] J. Milei,et al. Comparison of Lipid Peroxidation and Myocardial Damage Induced by Adriamycin and 4′-Epiadriamycin in Mice , 1985, Tumori.
[16] S. Marklund,et al. Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. , 1985, Mutation research.